
Standard Biotools Inc.
LABNasdaqCIK 1162194HealthcareFiscal year ends Dec 31
Reports and events: 345 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-08-0616:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091888 |
| 2024-07-3116:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-084362 |
| 2024-07-3116:12 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-088578 |
| 2024-07-0116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-076823 |
| 2024-06-0317:20 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-24-003487 |
| 2024-06-0306:05 ET | 8-K | 8.01 Other events | 0001104659-24-067384 |
| 2024-05-2216:54 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-24-003302 |
| 2024-05-0916:53 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057213 |
| 2024-05-0816:31 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-055791 |
| 2024-04-2617:01 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001104659-24-053067 |
| 2024-04-2508:06 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-051640 |
| 2024-03-2017:25 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-24-002111 |
| 2024-03-1809:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-035297 |
| 2024-03-0116:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023845 |
| 2024-02-2816:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-022060 |
| 2024-01-1916:33 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001104659-24-005246 |
| 2024-01-1214:04 ET | SC 13D/A | Ownership report, active investor, amended | 0001415889-24-001017 |
| 2024-01-0917:13 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-24-000217 |
| 2024-01-0817:00 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-24-000080 |
| 2024-01-0808:39 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-002092 |
| 2024-01-0508:53 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-001640 |
| 2023-12-2917:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-130528 |
| 2023-12-2619:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-128923 |
| 2023-12-1916:45 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-127352 |
| 2023-12-0417:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-123266 |
| 2023-11-2921:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-121725 |
| 2023-11-2216:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-23-054447 |
| 2023-11-2116:15 ET | 8-K | 8.01 Other events | 0001104659-23-120363 |
| 2023-11-0717:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060385 |
| 2023-11-0716:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-060237 |
| 2023-10-1616:30 ET | SC 13D | Ownership report, active investor | 0001140361-23-048351 |
| 2023-10-0408:08 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-106606 |
| 2023-08-0817:22 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-028287 |
| 2023-08-0816:28 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001162194-23-000055 |
| 2023-07-2817:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001162194-23-000053 |
| 2023-07-0317:17 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-23-003815 |
| 2023-06-1617:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001162194-23-000033 |
| 2023-05-1517:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950142-23-001458 |
| 2023-05-0917:13 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001162194-23-000024 |
| 2023-05-0916:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-23-001396 |
| 2023-05-0316:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950142-23-001328 |
| 2023-04-2816:30 ET | DEF 14A | Proxy statementPeriod 2023-06-14 | 0000950142-23-001246 |
| 2023-03-1616:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950142-23-000726 |
| 2023-03-1416:53 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001162194-23-000013 |
| 2023-03-1306:02 ET | 8-K | 8.01 Other events | 0000950142-23-000674 |
| 2023-02-1416:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-23-000411 |
| 2023-01-0908:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950142-23-000074 |
| 2022-12-3017:10 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-22-005340 |
| 2022-11-2816:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950142-22-003269 |
| 2022-11-0916:13 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001162194-22-000098 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.